Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,490 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Apple is taking a guarded AI route, leaning on partnerships and modest capex. The strategy could alter AI investing d...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
A clear, practical look at Bowhead Specialty's Q4 2025 earnings transcript. Learn what the numbers mean, which metric...
When an investment firm Absoluto Partners reveals a fresh stake in MercadoLibre, traders take note. This in-depth gui...
NVIDIA reports a surge in networking revenue and a strategic pivot toward AI infrastructure, signaling a shift from c...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
Celsius Holdings delivered a blowout Q4 and full-year results, sending shares higher as revenue accelerates and margi...
AI is accelerating productivity, yet the real payoff depends on how firms reallocate saved time. The resource realloc...
Fannie Freddie Boldly Remove the 620 FICO floor marks a historic change in conventional lending. This article explain...
First Solar has been delivering profits, but a heavy reliance on subsidies creates real investment risk. This article...
Target tops Q4 earnings expectations on cost discipline while generating robust cash flow. The focus center is target...